GNL Gut and Liver
  1. Hua-fang Bao, Cheng-cheng Hou, Bo Ye, Jun Zou, Dan Luo, Jian-fei Cai, Yan Shen, Jian-long Guan. Predictors of infliximab refractory intestinal Behçet’s syndrome: A retrospective cohort study from the Shanghai Behçet’s syndrome database. 2023;33:207
    https://doi.org/10.1093/mr/roab127
  2. João Araújo Correia, Jorge Crespo, Glória Alves, Fernando Salvador, João Matos-Costa, José Delgado Alves, Jorge Fortuna, Isabel Almeida, Ana Campar, Mariana Brandão, Raquel Faria, Daniela Marado, Susana Oliveira, Lelita Santos, Fátima Silva, Carlos Vasconcelos, Milene Fernandes, António Marinho. Biologic therapy in large and small vessels vasculitis, and Behçet’s disease: Evidence- and practice-based guidance. Autoimmunity Reviews 2023;22:103362
    https://doi.org/10.1016/j.autrev.2023.103362
  3. Alessandra Tesser, Alessia Pin, Elisabetta Mencaroni, Virginia Gulino, Alberto Tommasini. Vasculitis, Autoimmunity, and Cytokines: How the Immune System Can Harm the Brain. IJERPH 2021;18:5585
    https://doi.org/10.3390/ijerph18115585
  4. Anthony Nguyen, Shubhra Upadhyay, Muhammad Ali Javaid, Abdul Moiz Qureshi, Shahan Haseeb, Nismat Javed, Christopher Cormier, Asif Farooq, Abu Baker Sheikh. Behcet’s Disease: An In-Depth Review about Pathogenesis, Gastrointestinal Manifestations, and Management. Inflamm Intest Dis 2021;6:175
    https://doi.org/10.1159/000520696
  5. H. J. Kim, K.‑t. Kim, S.-G. Lee, Y. Kim. Successful combination therapy using adalimumab and 5-aminosalicylic acid for a resistant case of intestinal Behçet’s disease. Z Rheumatol 2020;79:702
    https://doi.org/10.1007/s00393-020-00816-0
  6. Shukai Zhan, Caiguang Liu, Na Li, Tong Li, Zhenyi Tian, Min Zhao, Dongxuan Wu, Minhu Chen, Zhirong Zeng, Xiaojun Zhuang. Anti-TNF-α agents for refractory intestinal Behçet’s disease: case series and meta-analysis. Therap Adv Gastroenterol 2022;15
    https://doi.org/10.1177/17562848221116666
  7. Tadakazu Hisamatsu, Makoto Naganuma, Philippe Pinton, Mitsuhiro Takeno. Behçet’s disease: incidence, prevalence, and real-word data on the use of biologic agents in Japan. J Gastroenterol 2024
    https://doi.org/10.1007/s00535-024-02191-y
  8. Giorgio Costagliola, Susanna Cappelli, Rita Consolini.

    Behçet’s Disease in Children: Diagnostic and Management Challenges

    . TCRM 2020;Volume 16:495
    https://doi.org/10.2147/TCRM.S232660
  9. Jae Hee Cheon, Hyun-Soo Kim, Dong Soo Han, Sung Kook Kim, Sung Jae Shin, Joo Sung Kim, Byong Duk Ye, Geun Am Song, YoungJa Lee, Youngdoe Kim, Yoosun Lee, Won Ho Kim. Efficacy and Safety of Infliximab in Intestinal Behçet’s Disease: A Multicenter, Phase 3 Study (BEGIN). Gut and Liver 2023;17:777
    https://doi.org/10.5009/gnl220278
  10. Sumei Sha, Bin Xu, Kairuo Wang, Chenyang Qiao, Haitao Shi, Jiong Jiang, Xiaojing Quan, Xin Liu. Case report: Successful remission with upadacitinib in a young patient with anti-TNF-refractory intestinal Behçet’s disease. Front. Immunol. 2024;15
    https://doi.org/10.3389/fimmu.2024.1483993
  11. Haruka Miyazaki, Daisuke Watanabe, Norihiro Okamoto, Eri Tokunaga, Yuna Ku, Haruka Takenaka, Namiko Hoshi, Makoto Ooi, Yuzo Kodama. Efficacy and predictor of anti-TNFα agents in patients with intestinal Behçet's disease. BMC Gastroenterol 2022;22
    https://doi.org/10.1186/s12876-022-02221-0
  12. Eun Ae Kang, Jung Won Park, Yehyun Park, Soo Jung Park, Tae Il Kim, Won Ho Kim, Min Soo Cho, Jae Hee Cheon. C-reactive protein is associated with postoperative outcomes in patients with intestinal Behçet’s disease. BMC Gastroenterol 2021;21
    https://doi.org/10.1186/s12876-021-01922-2
  13. Jongwook Yu, Sung Jae Shin, Yune-Jung Park, Hyung Wook Kim, Bo-In Lee, Byong Duk Ye, Geun-Tae Kim, Sung Kook Kim, Joo Sung Kim, Young-Ho Kim, Seonjeong Jeong, Jae Hee Cheon. Effectiveness and safety of adalimumab in patients with intestinal Behçet’s disease: a real-world prospective observational study in South Korea. BMC Gastroenterol 2023;23
    https://doi.org/10.1186/s12876-023-03090-x
© 2023. Gut and Liver. / Powered by INFOrang Co., Ltd